يعرض 1 - 10 نتائج من 72 نتيجة بحث عن '"G.J.M. Creemers"', وقت الاستعلام: 0.88s تنقيح النتائج
  1. 1

    المساهمون: Surgery, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: European Journal of Surgical Oncology, 47(9), 2429-2435. ELSEVIER SCI LTD

    وصف الملف: application/pdf

  2. 2

    المساهمون: Surgery, CCA - Cancer Treatment and quality of life, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: Colorectal Disease, 23(5), 1120-1131. Wiley-Blackwell
    Colorectal Disease, 23(5), 1120-1131. Wiley
    Voogt, E L K, van Zoggel, D M G I, Kusters, M, Nieuwenhuijzen, G A P, Cnossen, J S, Creemers, G J, van Lijnschoten, G, Nederend, J, Roef, M J, Burger, J W A & Rutten, H J T 2021, ' Impact of a history of metastases or synchronous metastases on survival in patients with locally recurrent rectal cancer ', Colorectal Disease, vol. 23, no. 5, pp. 1120-1131 . https://doi.org/10.1111/codi.15537Test

    وصف الملف: application/pdf

  3. 3

    المساهمون: Epidemiologie, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Surgery

    المصدر: Annals of Surgical Oncology, 28(13), 9073-9083. Springer, Cham
    Annals of Surgical Oncology
    Annals of Surgical Oncology, 28(13), 9073-9083. Springer New York

    وصف الملف: application/pdf

  4. 4

    المساهمون: Service d'Oncologie Médicale [CHU Saint -Antoine], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Saint-Antoine [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Interactions hôte-greffon-tumeur, ingénierie cellulaire et génique - UFC (UMR INSERM 1098) (RIGHT), Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang [Bourgogne-Franche-Comté] (EFS [Bourgogne-Franche-Comté])-Université de Franche-Comté (UFC), Université Bourgogne Franche-Comté [COMUE] (UBFC)-Université Bourgogne Franche-Comté [COMUE] (UBFC), HUS Comprehensive Cancer Center, Department of Oncology, Clinicum

    المصدر: Annals of Oncology
    Annals of Oncology, Elsevier, 2020, 31, pp.246-256. ⟨10.1016/j.annonc.2019.12.006⟩

  5. 5

    المساهمون: Internal medicine, APH - Methodology, APH - Quality of Care, Surgery, CCA - Cancer Treatment and quality of life, VU University medical center, Graduate School, Medical Psychology, Oncology, APH - Mental Health, APH - Personalized Medicine, CCA - Cancer Treatment and Quality of Life, Amsterdam Gastroenterology Endocrinology Metabolism, Infectious diseases, APH - Global Health, APH - Aging & Later Life, Medical and Clinical Psychology

    المصدر: On behalf of the Dutch Upper GI Cancer Group (DUCG) 2021, ' Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study ', Gastric Cancer, vol. 24, no. 6, pp. 1203-1212 . https://doi.org/10.1007/s10120-021-01209-1Test
    Gastric Cancer, 24(6), 1203-1212. Springer Japan
    Gastric cancer, 24(6), 1203-1212. Springer Japan
    Gastric Cancer
    Gastric Cancer, 24, 6, pp. 1203-1212
    Gastric Cancer, 24(6), 1203-1212. SPRINGER
    Gastric Cancer, 24, 1203-1212

    وصف الملف: application/pdf

  6. 6
  7. 7

    المساهمون: Surgery, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), Epidemiologie, Graduate School, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, CCA - Cancer Treatment and quality of life, Internal medicine, VU University medical center, Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Guided Treatment in Optimal Selected Cancer Patients (GUTS)

    المصدر: for the Dutch Pancreatic Cancer Group 2021, ' The treatment and survival of elderly patients with locally advanced pancreatic cancer : A post-hoc analysis of a multicenter registry ', Pancreatology, vol. 21, no. 1, pp. 163-169 . https://doi.org/10.1016/j.pan.2020.11.012Test
    Pancreatology, 21, 163-169
    Pancreatology, 21(1), 163-169. Elsevier
    Pancreatology, 21, 1, pp. 163-169
    Pancreatology, 21(1), 163-169. S. Karger AG
    Pancreatology, 21(1), 163-169. ELSEVIER SCIENCE BV

    وصف الملف: application/pdf

  8. 8

    المساهمون: Dutch Pancreatic Cancer Group, Surgery, CCA - Cancer Treatment and quality of life, Amsterdam Gastroenterology Endocrinology Metabolism, Radiology and nuclear medicine, Internal medicine, MUMC+: MA Heelkunde (9), Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Guided Treatment in Optimal Selected Cancer Patients (GUTS), Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), Institut Català de la Salut, [Walma MS, Rombouts SJ, Brada LJH] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. Departments of Surgery, Radiology and Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. [Borel Rinkes IH, Bruijnen RC] Departments of Surgery, Radiology and Medical Oncology, UMC Utrecht Cancer Center and St Antonius Hospital Nieuwegein: Regional Academic Cancer Center Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. [Bosscha K] Departments of Surgery and Medical Oncology, Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands. [Pando E] Servei de Cirurgia Hepatobiliopancreàtica i Trasplantaments, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, CCA - Cancer Treatment and Quality of Life, Radiology and Nuclear Medicine, Amsterdam Cardiovascular Sciences, Cancer Center Amsterdam, Laboratory for General Clinical Chemistry, Oncology

    المصدر: Trials, 22, 1
    Trials
    Trials, 22
    Trials, 22(1):313. BioMed Central
    Dutch Pancreatic Cancer Group 2021, ' Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial ', Trials, vol. 22, no. 1, 313 . https://doi.org/10.1186/s13063-021-05248-yTest
    Trials, 22(1):313. BioMed Central Ltd
    TRIALS, 22(1):313, 1-12. BMC
    Scientia
    Trials, Vol 22, Iss 1, Pp 1-12 (2021)

    مصطلحات موضوعية: Oncology, Medicine (General), Radiofrequency ablation, FOLFIRINOX, SURGERY, medicine.medical_treatment, Locally advanced pancreatic cancer, INTERNATIONAL STUDY-GROUP, Medicine (miscellaneous), 030230 surgery, law.invention, Study Protocol, Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14], 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Quimioteràpia, Clinical endpoint, Multicenter Studies as Topic, Pharmacology (medical), Overall survival, neoplasias::neoplasias por localización::neoplasias del sistema digestivo::neoplasias pancreáticas [ENFERMEDADES], Otros calificadores::/terapia [Otros calificadores], Netherlands, Randomized Controlled Trials as Topic, terapéutica::terapéutica::farmacoterapia::protocolos antineoplásicos::terapéutica::farmacoterapia::protocolos de quimioterapia antineoplásica combinada [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], Extirpació (Cirurgia), TUMORS, Progression-Free Survival, 030220 oncology & carcinogenesis, SURVIVAL, terapéutica::tratamiento de radiofrecuencia::ablación por radiofrecuencia [TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS], medicine.drug, medicine.medical_specialty, CLINICAL-OUTCOMES, Therapeutics::Radiofrequency Therapy::Radiofrequency Ablation [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], 03 medical and health sciences, R5-920, Therapeutics::Therapeutics::Drug Therapy::Antineoplastic Protocols::Therapeutics::Drug Therapy::Antineoplastic Combined Chemotherapy Protocols [ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT], Internal medicine, Pancreatic cancer, Pàncrees - Càncer - Tractament, medicine, Humans, Chemotherapy, Neoplasms::Neoplasms by Site::Digestive System Neoplasms::Pancreatic Neoplasms [DISEASES], business.industry, Cancer, ADENOCARCINOMA, Other subheadings::/therapy [Other subheadings], medicine.disease, PHASE-III, Gemcitabine, Pancreatic Neoplasms, DEFINITION, GEMCITABINE, Human medicine, business

    وصف الملف: application/pdf

  9. 9

    المساهمون: Surgery, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Epidemiologie

    المصدر: European Journal of Surgical Oncology, 47(5), 1026-1033. W.B. Saunders
    European Journal of Surgical Oncology, 47(5), 1026-1033. ELSEVIER SCI LTD

  10. 10

    المساهمون: Radiotherapie, Surgery, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

    المصدر: Annals of Surgical Oncology, 27(9), 3503-3513. Springer, Cham
    Annals of Surgical Oncology, 27(9), 3503-3513. Springer New York
    Voogt, E L K, van Zoggel, D M G I, Kusters, M, Nieuwenhuijzen, G A P, Bloemen, J G, Peulen, H M U, Creemers, G J M, van Lijnschoten, G, Nederend, J, Roef, M J, Burger, J W A & Rutten, H J T 2020, ' Improved Outcomes for Responders After Treatment with Induction Chemotherapy and Chemo(re)irradiation for Locally Recurrent Rectal Cancer ', Annals of Surgical Oncology, vol. 27, no. 9, pp. 3503-3513 . https://doi.org/10.1245/s10434-020-08362-4Test

    وصف الملف: application/pdf